1-(4-{3-[4-(6-Fluoro-benzo[d]isoxazol-3-yl)-piperidin-1-yl]-propoxy}-3-methoxy-phenyl)-propan-1-one

ID: ALA14163

Cas Number: 133455-04-6

PubChem CID: 10071945

Max Phase: Preclinical

Molecular Formula: C25H29FN2O4

Molecular Weight: 440.52

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  CCC(=O)c1ccc(OCCCN2CCC(c3noc4cc(F)ccc34)CC2)c(OC)c1

Standard InChI:  InChI=1S/C25H29FN2O4/c1-3-21(29)18-5-8-22(24(15-18)30-2)31-14-4-11-28-12-9-17(10-13-28)25-20-7-6-19(26)16-23(20)32-27-25/h5-8,15-17H,3-4,9-14H2,1-2H3

Standard InChI Key:  NDYOGQKCYHHFLA-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 32 35  0  0  0  0  0  0  0  0999 V2000
    5.2667   -6.1750    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.2750   -5.3417    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8417   -5.3417    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.5542   -6.5875    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.8375   -6.1667    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.5542   -1.1417    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.0292   -3.6042    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.1250   -4.9292    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1250   -6.5875    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.7542   -0.9292    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.1667   -1.5125    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.8542   -4.7667    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.1375   -0.5667    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.3792   -2.3042    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.7625   -1.9417    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.9292    0.2333    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   11.1750   -2.5250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4125   -6.1750    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.6542   -4.9792    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6417   -3.9667    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.2292   -3.3917    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.2375   -4.4042    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4125   -5.3500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.3667   -1.2917    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.6917   -6.5875    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    9.7917   -2.8792    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    7.6167   -3.0292    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.4125   -3.2417    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.9292   -0.7792    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.0000   -2.6667    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.1542   -0.5000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.5167   -0.2042    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  2  0
  3  2  1  0
  4  1  1  0
  5  4  1  0
  6 15  2  0
  7 21  1  0
  8  3  2  0
  9  5  2  0
 10 11  2  0
 11 14  1  0
 12  2  1  0
 13  6  1  0
 14 26  1  0
 15 17  1  0
 16 13  2  0
 17 14  2  0
 18  9  1  0
 19 12  1  0
 20 12  1  0
 21 20  1  0
 22 19  1  0
 23  8  1  0
 24 11  1  0
 25 18  1  0
 26 30  1  0
 27  7  1  0
 28 27  1  0
 29 13  1  0
 30 28  1  0
 31 24  1  0
 32 29  1  0
  3  5  1  0
 22  7  1  0
 23 18  2  0
 10  6  1  0
M  END

Associated Targets(non-human)

Mus musculus (284745 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Rattus norvegicus (775804 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Drd2 Dopamine D2 receptor (7893 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Htr2b Serotonin 2 (5-HT2) receptor (2078 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Drd2 Dopamine D2 receptor/Serotonin 2 (5-HT2) receptor (132 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 440.52Molecular Weight (Monoisotopic): 440.2111AlogP: 5.22#Rotatable Bonds: 9
Polar Surface Area: 64.80Molecular Species: NEUTRALHBA: 6HBD:
#RO5 Violations: 1HBA (Lipinski): 6HBD (Lipinski): #RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: 7.91CX LogP: 3.92CX LogD: 3.30
Aromatic Rings: 3Heavy Atoms: 32QED Weighted: 0.34Np Likeness Score: -1.19

References

1. Strupczewski JT, Bordeau KJ, Chiang Y, Glamkowski EJ, Conway PG, Corbett R, Hartman HB, Szewczak MR, Wilmot CA, Helsley GC..  (1995)  3-[[(Aryloxy)alkyl]piperidinyl]-1,2-benzisoxazoles as D2/5-HT2 antagonists with potential atypical antipsychotic activity: antipsychotic profile of iloperidone (HP 873).,  38  (7): [PMID:7707315] [10.1021/jm00007a009]

Source